Agenda

Agenda

Tuesday, November 14

Times in bold are shown as Greenwich Mean Time (GMT).

11:00

Opening address & Poster session
11:15
12:15 (CET)
06:15 (EST)
03:15 (PST)

Harnessing the power of tumor organoids: Next-gen drug screening with live-cell imaging
Dr. Christophe Deben, Assistant Experimental Oncology, Centre for Oncological Research, University of Antwerp
12:00
13:00 (CET)
07:00 (EST)
04:00 (PST)

Precision oncology in practice: The path to clinical utility
Dr. Ofer Sharon, CEO, OncoHost
12:45
13:45 (CET)
07:45 (EST)
04:45 (PST)

ADME: The building block to successful drug discovery
Samer Sansil, Scientist, Moffitt Cancer Centre
13:30
14:30 (CET)
08:30 (EST)
05:30 (PST)

Analytical considerations for cfDNA biomarker analysis powered by NGS
Krishna Amin, Senior Global Product Manager, Targeted & Enterprise Genomics & Dr. Leif Schauser, Director, Product Management, Genome Analysis, QIAGEN
14:15
15:15 (CET)
09:15 (EST)
06:15 (PST)

Focus on the key players: Surveying the proteome with high-density antibody panels
Dr. Valerie Sloane Jones, Director, Marketing and Technical Support, RayBiotech, Inc.
15:00
16:00 (CET)
10:00 (EST)
07:00 (PST)

Molecular changes in dense breast tissue
Prof. Noelle Cutter, Associate Professor, Molloy College
15:45
16:45 (CET)
10:45 (EST)
07:45 (PST)
Advancing precision oncology with a portfolio of tumor genomic profiling solutions
Akanksha Khare, Senior Scientist, R&D, Agilent Technologies
16:30
17:30 (CET)
11:30 (EST)
08:30 (PST)

Solutions for culturing, maintaining and characterizing induced pluripotent stem cells
Dr. Daryl Cole, Scientist, Sartorius
17:15
18:15 (CET)
12:15 (EST)
09:15 (PST)

Guido BaechlerBreakthrough research advances early detection in colorectal cancer
Guido Baechler, CEO, Mainz Biomed
18:00
19:00 (CET)
13:00 (EST)
10:00 (PST)

Dr. Trevor Pitcher, Sr. Director, Medical Affairs (Publications and Medical Information), Biodesix, IncHarnessing the power of ddPCR to advance precision oncology
Dr. Trevor Pitcher, Sr. Director, Medical Affairs (Publications and Medical Information), Biodesix, Inc
18:45
19:45 (CET)
13:45 (EST)
10:45 (PST)

Advantages of new AI-based stain-free cell analysis for cancer research
Tecan